Global and United States Tuberculosis Therapeutics Market Report & Forecast 2023-2028

Report ID: 1835156 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Tuberculosis Therapeutics Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Tuberculosis Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Tuberculosis Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Tuberculosis Therapeutics Market Size for the Year 2017-2028
    1.3 Tuberculosis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Tuberculosis Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Tuberculosis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Tuberculosis Therapeutics Market Dynamics
        1.4.1 Tuberculosis Therapeutics Industry Trends
        1.4.2 Tuberculosis Therapeutics Market Drivers
        1.4.3 Tuberculosis Therapeutics Market Challenges
        1.4.4 Tuberculosis Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Tuberculosis Therapeutics by Type
    2.1 Tuberculosis Therapeutics Market Segment by Type
        2.1.1 Isoniazid
        2.1.2 Rifampin
        2.1.3 Pyrazinamide
        2.1.4 Hydrazine Derivatives
        2.1.5 Miscellaneous Anti-Tubercular Drugs
        2.1.6 Ethambutol
        2.1.7 Others
    2.2 Global Tuberculosis Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Tuberculosis Therapeutics Market Size by Type (2017-2028)
    2.4 United States Tuberculosis Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Tuberculosis Therapeutics Market Size by Type (2017-2028)
3 Tuberculosis Therapeutics by Application
    3.1 Tuberculosis Therapeutics Market Segment by Application
        3.1.1 Hospital
        3.1.2 Pharmacy
        3.1.3 Clinics
        3.1.4 Others
    3.2 Global Tuberculosis Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Tuberculosis Therapeutics Market Size by Application (2017-2028)
    3.4 United States Tuberculosis Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Tuberculosis Therapeutics Market Size by Application (2017-2028)
4 Global Tuberculosis Therapeutics Competitor Landscape by Company
    4.1 Global Tuberculosis Therapeutics Market Size by Company
        4.1.1 Top Global Tuberculosis Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Tuberculosis Therapeutics Revenue by Player (2017-2022)
    4.2 Global Tuberculosis Therapeutics Concentration Ratio (CR)
        4.2.1 Tuberculosis Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Tuberculosis Therapeutics in 2021
        4.2.3 Global Tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Tuberculosis Therapeutics Headquarters, Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Tuberculosis Therapeutics Headquarters and Area Served
        4.3.2 Global Tuberculosis Therapeutics Companies Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Tuberculosis Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Tuberculosis Therapeutics Market Size by Company
        4.5.1 Top Tuberculosis Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Tuberculosis Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Tuberculosis Therapeutics Market Size by Region
    5.1 Global Tuberculosis Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Tuberculosis Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Tuberculosis Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Tuberculosis Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Tuberculosis Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Tuberculosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Tuberculosis Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Tuberculosis Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Tuberculosis Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Tuberculosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Tuberculosis Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Tuberculosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Tuberculosis Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Tuberculosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Aventis Pharmaceuticals
        7.1.1 Aventis Pharmaceuticals Company Details
        7.1.2 Aventis Pharmaceuticals Business Overview
        7.1.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Introduction
        7.1.4 Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.1.5 Aventis Pharmaceuticals Recent Development
    7.2 Sanofi -Aventis
        7.2.1 Sanofi -Aventis Company Details
        7.2.2 Sanofi -Aventis Business Overview
        7.2.3 Sanofi -Aventis Tuberculosis Therapeutics Introduction
        7.2.4 Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.2.5 Sanofi -Aventis Recent Development
    7.3 Versapharma Incorporated
        7.3.1 Versapharma Incorporated Company Details
        7.3.2 Versapharma Incorporated Business Overview
        7.3.3 Versapharma Incorporated Tuberculosis Therapeutics Introduction
        7.3.4 Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.3.5 Versapharma Incorporated Recent Development
    7.4 Sigma Pharmaceutical Pty
        7.4.1 Sigma Pharmaceutical Pty Company Details
        7.4.2 Sigma Pharmaceutical Pty Business Overview
        7.4.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Introduction
        7.4.4 Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.4.5 Sigma Pharmaceutical Pty Recent Development
    7.5 Novartis AG
        7.5.1 Novartis AG Company Details
        7.5.2 Novartis AG Business Overview
        7.5.3 Novartis AG Tuberculosis Therapeutics Introduction
        7.5.4 Novartis AG Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.5.5 Novartis AG Recent Development
    7.6 Hoffmann-La Roche
        7.6.1 Hoffmann-La Roche Company Details
        7.6.2 Hoffmann-La Roche Business Overview
        7.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Introduction
        7.6.4 Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.6.5 Hoffmann-La Roche Recent Development
    7.7 Bayer Health Care
        7.7.1 Bayer Health Care Company Details
        7.7.2 Bayer Health Care Business Overview
        7.7.3 Bayer Health Care Tuberculosis Therapeutics Introduction
        7.7.4 Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2017-2022)
        7.7.5 Bayer Health Care Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Tuberculosis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Tuberculosis Therapeutics Market Trends
    Table 3. Tuberculosis Therapeutics Market Drivers
    Table 4. Tuberculosis Therapeutics Market Challenges
    Table 5. Tuberculosis Therapeutics Market Restraints
    Table 6. Global Tuberculosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tuberculosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tuberculosis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tuberculosis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tuberculosis Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tuberculosis Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Tuberculosis Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Tuberculosis Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tuberculosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Therapeutics as of 2021)
    Table 15. Top Players of Tuberculosis Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Tuberculosis Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Tuberculosis Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Tuberculosis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Tuberculosis Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Tuberculosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Tuberculosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Tuberculosis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Tuberculosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Tuberculosis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Tuberculosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Tuberculosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Tuberculosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Aventis Pharmaceuticals Company Details
    Table 31. Aventis Pharmaceuticals Business Overview
    Table 32. Aventis Pharmaceuticals Tuberculosis Therapeutics Product
    Table 33. Aventis Pharmaceuticals Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Aventis Pharmaceuticals Recent Development
    Table 35. Sanofi -Aventis Company Details
    Table 36. Sanofi -Aventis Business Overview
    Table 37. Sanofi -Aventis Tuberculosis Therapeutics Product
    Table 38. Sanofi -Aventis Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Sanofi -Aventis Recent Development
    Table 40. Versapharma Incorporated Company Details
    Table 41. Versapharma Incorporated Business Overview
    Table 42. Versapharma Incorporated Tuberculosis Therapeutics Product
    Table 43. Versapharma Incorporated Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Versapharma Incorporated Recent Development
    Table 45. Sigma Pharmaceutical Pty Company Details
    Table 46. Sigma Pharmaceutical Pty Business Overview
    Table 47. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product
    Table 48. Sigma Pharmaceutical Pty Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Sigma Pharmaceutical Pty Recent Development
    Table 50. Novartis AG Company Details
    Table 51. Novartis AG Business Overview
    Table 52. Novartis AG Tuberculosis Therapeutics Product
    Table 53. Novartis AG Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Novartis AG Recent Development
    Table 55. Hoffmann-La Roche Company Details
    Table 56. Hoffmann-La Roche Business Overview
    Table 57. Hoffmann-La Roche Tuberculosis Therapeutics Product
    Table 58. Hoffmann-La Roche Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Hoffmann-La Roche Recent Development
    Table 60. Bayer Health Care Company Details
    Table 61. Bayer Health Care Business Overview
    Table 62. Bayer Health Care Tuberculosis Therapeutics Product
    Table 63. Bayer Health Care Revenue in Tuberculosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Bayer Health Care Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tuberculosis Therapeutics Product Picture
    Figure 2. Global Tuberculosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tuberculosis Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Tuberculosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Tuberculosis Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Tuberculosis Therapeutics Market Share in Global 2017-2028
    Figure 7. Tuberculosis Therapeutics Report Years Considered
    Figure 8. Product Picture of Isoniazid
    Figure 9. Product Picture of Rifampin
    Figure 10. Product Picture of Pyrazinamide
    Figure 11. Product Picture of Hydrazine Derivatives
    Figure 12. Product Picture of Miscellaneous Anti-Tubercular Drugs
    Figure 13. Product Picture of Ethambutol
    Figure 14. Product Picture of Others
    Figure 15. Global Tuberculosis Therapeutics Market Share by Type in 2022 & 2028
    Figure 16. Global Tuberculosis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global Tuberculosis Therapeutics Market Share by Type (2017-2028)
    Figure 18. United States Tuberculosis Therapeutics Market Share by Type in 2022 & 2028
    Figure 19. United States Tuberculosis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States Tuberculosis Therapeutics Market Share by Type (2017-2028)
    Figure 21. Product Picture of Hospital
    Figure 22. Product Picture of Pharmacy
    Figure 23. Product Picture of Clinics
    Figure 24. Product Picture of Others
    Figure 25. Global Tuberculosis Therapeutics Market Share by Application in 2022 & 2028
    Figure 26. Global Tuberculosis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global Tuberculosis Therapeutics Market Share by Application (2017-2028)
    Figure 28. United States Tuberculosis Therapeutics Market Share by Application in 2022 & 2028
    Figure 29. United States Tuberculosis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States Tuberculosis Therapeutics Market Share by Application (2017-2028)
    Figure 31. North America Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. U.S. Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Taiwan Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Philippines Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. U.A.E Tuberculosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Aventis Pharmaceuticals Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 60. Sanofi -Aventis Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 61. Versapharma Incorporated Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 62. Sigma Pharmaceutical Pty Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 63. Novartis AG Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 64. Hoffmann-La Roche Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 65. Bayer Health Care Revenue Growth Rate in Tuberculosis Therapeutics Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aventis Pharmaceuticals
Sanofi -Aventis
Versapharma Incorporated
Sigma Pharmaceutical Pty
Novartis AG
Hoffmann-La Roche
Bayer Health Care
Frequently Asked Questions
Tuberculosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tuberculosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tuberculosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports